W ith a stated goal of making the health care system more sustainable while delivering more effective treatments to Canadians, the federal government has announced it is investing more than $67 million in research into "personalized medicine."
The money is to be used for a research competition led by Genome Canada, in collaboration with the Canadian Institutes of Health Research (CIHR) and the Cancer Stem Cell Consortium, the government announced on January 31, 2012.
The research will focus on development of treatments that can be tailored to an individual's genetic makeup and environment -what the government calls "a personalized molecular medicine approach." This approach "…is expected to lead to better health outcomes, improved treatments and reduction in toxicity due to variable or adverse drug outcomes," said the government in a news release.
Advances in personalized medicine will help transform health care away from a "onesize-fits-all" system towards a system of "predictive, preventive and precision care," the government said, adding that personalized medicine holds particular promise in such areas as oncology, cardiovascular diseases, neurodegenerative diseases, diabetes, pain and Alzheimer's disease. n
